BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26702134)

  • 1. Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating.
    Ringel-Kulka T; Benson AK; Carroll IM; Kim J; Legge RM; Ringel Y
    Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G417-26. PubMed ID: 26702134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Carroll IM; Ringel-Kulka T; Siddle JP; Ringel Y
    Neurogastroenterol Motil; 2012 Jun; 24(6):521-30, e248. PubMed ID: 22339879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
    Chen J; Lan H; Li C; Xie Y; Cheng X; Xia R; Ke C; Liang X
    J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
    Lyra A; Rinttilä T; Nikkilä J; Krogius-Kurikka L; Kajander K; Malinen E; Mättö J; Mäkelä L; Palva A
    World J Gastroenterol; 2009 Dec; 15(47):5936-45. PubMed ID: 20014457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Zhu X; Hong G; Li Y; Yang P; Cheng M; Zhang L; Li Y; Ji L; Li G; Chen C; Zhong C; Jin Y; Yang M; Xiong H; Qian W; Ding Z; Ning K; Hou X
    Microbiol Spectr; 2021 Dec; 9(3):e0125521. PubMed ID: 34937163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Intestinal Microbiota and Irritable Bowel Syndrome.
    Ringel Y; Ringel-Kulka T
    J Clin Gastroenterol; 2015; 49 Suppl 1():S56-9. PubMed ID: 26447966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
    Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
    Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation.
    Tanaka Y; Yamashita R; Kawashima J; Mori H; Kurokawa K; Fukuda S; Gotoh Y; Nakamura K; Hayashi T; Kasahara Y; Sato Y; Fukudo S
    J Gastroenterol; 2022 Oct; 57(10):748-760. PubMed ID: 35908139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
    Li G; Yang M; Jin Y; Li Y; Qian W; Xiong H; Song J; Hou X
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1220-1226. PubMed ID: 29194775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome.
    Hou Y; Dong L; Lu X; Shi H; Xu B; Zhong W; Ma L; Wang S; Yang C; He X; Zhao Y; Wang S
    Dig Dis Sci; 2022 Dec; 67(12):5580-5592. PubMed ID: 35879512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Dietary Habits and Fecal Microbiota Composition in Irritable Bowel Syndrome Patients: A Pilot Study.
    Altomare A; Del Chierico F; Rocchi G; Emerenziani S; Nuglio C; Putignani L; Angeletti S; Lo Presti A; Ciccozzi M; Russo A; Cocca S; Ribolsi M; Muscaritoli M; Cicala M; Guarino MPL
    Nutrients; 2021 Apr; 13(5):. PubMed ID: 33925672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome.
    Choo C; Mahurkar-Joshi S; Dong TS; Lenhart A; Lagishetty V; Jacobs JP; Labus JS; Jaffe N; Mayer EA; Chang L
    Am J Physiol Gastrointest Liver Physiol; 2022 Aug; 323(2):G134-G143. PubMed ID: 35726867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.
    Labus JS; Hollister EB; Jacobs J; Kirbach K; Oezguen N; Gupta A; Acosta J; Luna RA; Aagaard K; Versalovic J; Savidge T; Hsiao E; Tillisch K; Mayer EA
    Microbiome; 2017 May; 5(1):49. PubMed ID: 28457228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.
    Kassinen A; Krogius-Kurikka L; Mäkivuokko H; Rinttilä T; Paulin L; Corander J; Malinen E; Apajalahti J; Palva A
    Gastroenterology; 2007 Jul; 133(1):24-33. PubMed ID: 17631127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome.
    Carroll IM; Ringel-Kulka T; Keku TO; Chang YH; Packey CD; Sartor RB; Ringel Y
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G799-807. PubMed ID: 21737778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.